drugset
drugset / Trial / NCT05838833

Ointment to Prevent Scar After Thyroidectomy

NCT05838833 ↗

Phase 2 Unknown 75 enrolled Innovo Therapeutics, Inc.
RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this study is to evaluate the efficacy and Safety of INV-001 administration for the prevention of scar after thyroidectomy. Participants will be asked to apply ointment on their scar for 12 weeks.

Timeline

Start
2023-02-14
Primary completion
2023-12
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Subject INV-001 Unknown — —

Indications

No indication recorded.